AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 208 filers reported holding AMICUS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,480 | -93.5% | 40,500 | -94.1% | 0.02% | -94.5% |
| Q1 2023 | $7,585,050 | +57.5% | 683,954 | +73.4% | 0.31% | +29.5% |
| Q4 2022 | $4,815,758 | +1154.1% | 394,411 | +873.9% | 0.24% | +1216.7% |
| Q1 2022 | $384,000 | -81.2% | 40,500 | -77.2% | 0.02% | -84.1% |
| Q4 2021 | $2,048,000 | +2.2% | 177,346 | -15.5% | 0.11% | +11.9% |
| Q3 2021 | $2,004,000 | +413.8% | 209,835 | +424.6% | 0.10% | +260.7% |
| Q4 2019 | $390,000 | -80.3% | 40,000 | -83.8% | 0.03% | -81.1% |
| Q3 2019 | $1,982,000 | -37.7% | 247,046 | +16.7% | 0.15% | +9.6% |
| Q1 2018 | $3,183,000 | -19.3% | 211,618 | -22.8% | 0.14% | -34.8% |
| Q4 2017 | $3,945,000 | -35.2% | 274,122 | -32.1% | 0.21% | -32.6% |
| Q3 2017 | $6,085,000 | +826.2% | 403,500 | +354.4% | 0.31% | +729.7% |
| Q3 2016 | $657,000 | -66.8% | 88,800 | -51.2% | 0.04% | -69.7% |
| Q1 2015 | $1,976,000 | -40.6% | 182,000 | -54.5% | 0.12% | -69.0% |
| Q4 2014 | $3,328,000 | – | 400,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Morgenthaler Management Partners IX, LLC | 1,783,948 | $17,304,000 | 18.83% |
| FRAZIER MANAGEMENT LLC | 2,918,291 | $28,307,000 | 11.84% |
| Avoro Capital Advisors LLC | 3,515,611 | $34,101,000 | 11.75% |
| Perceptive Advisors | 15,239,444 | $147,823,000 | 10.94% |
| Redmile Group, LLC | 10,280,620 | $99,722,000 | 7.46% |
| ACUTA CAPITAL PARTNERS, LLC | 1,502,661 | $14,576,000 | 6.97% |
| SECTORAL ASSET MANAGEMENT INC | 7,973,436 | $77,342,000 | 3.30% |
| Asymmetry Capital Management, L.P. | 195,206 | $1,893,000 | 2.86% |
| Convector Capital Management, LP | 210,500 | $2,042,000 | 1.92% |
| Palo Alto Investors LP | 3,551,173 | $34,446,000 | 1.92% |